Uveal Melanoma UK national guidelines: 2023 update.
No Thumbnail Available
Authors
Carter T.J.
Broadfoot J.
Coupland S.E.
Damato B.
Evans H.
Fenwick S.
Khoja L.
Krausa T.
Lewis R.
Nathan P.
Check for full-text access
Issue Date
2025
Type
Article
Language
Keywords
Alternative Title
Abstract
UK Guidelines for the management of uveal melanoma (UM) were first published in 2015 using an evidence-based systematic approach. The primary aim of this guideline was to optimise patient care by providing recommendations based on the best available scientific evidence. The resulting guideline reflected the strengths and weaknesses of the available evidence, made recommendations that were clinically impactful around prognostication, surveillance, and treatment for patients with primary lesions and metastatic disease. The guideline development process and content met the standards required by NICE and were ultimately NICE accredited. Here, we present an update to these guidelines, highlighting where practice or treatment has changed to such an extent that the original recommendations are now out of date. Presented here are updated guidelines on molecular and genetic testing, management of metastatic disease and clinical surveillance. Copyright © 2025 The Authors
Description
Citation
Publisher
License
Journal
European journal of cancer
Volume
228